Literature DB >> 12127816

Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions.

Nagato Katsura1, Iwao Ikai, Toshihiro Mitaka, Tomohiro Shiotani, Satoshi Yamanokuchi, Shinichi Sugimoto, Akiyoshi Kanazawa, Hiroaki Terajima, Yohichi Mochizuki, Yoshio Yamaoka.   

Abstract

BACKGROUND: The aim of this study was to develop a suitable method for the prolonged culture and maintenance of human hepatocytes with preservation of both proliferative capacity and differentiated functions.
MATERIALS AND METHODS: Primary human hepatocytes were isolated from small pieces of liver tissue obtained from 15 patients who underwent hepatic resection. Hepatocytes were cultured in keratinocyte-stimulating factor medium supplemented with 10% human serum, 10 mM nicotinamide, 10 ng/ml epidermal growth factor, 0.5 microg/ml insulin, 10(-7) M dexamethasone, and antibiotics. Hepatic differentiation and function were analyzed by immunocytochemistry, Western blot, ELISA, lidocaine metabolism, and urea synthesis. Ultrastructural analysis of cultured hepatocytes was performed by electron microscopy.
RESULTS: Many primary hepatocytes were maintained for more than 56 days. Hepatocytes proliferated during the initial 14 days, and bromodeoxyuridine labeling indices were 15.2, 12.2, and 6.2% at days 5, 10, and 15, respectively. Electron micrographs of the hepatocytes at day 28 demonstrated numerous mitochondria, rough endoplasmic reticulum, large peroxisomes, and glycogen granules. Albumin secretion increased for the first 14 days and then gradually decreased thereafter but was maintained at levels greater than 2 microg/ml/h until day 56. alpha(1)-Antitrypsin, alpha(1)-antichymotrypsin, and ceruloplasmin production was also observed at day 56, while lidocaine metabolism and urea synthesis were maintained for a long time.
CONCLUSION: This hepatocyte culture method facilitates the prolonged culture of primary human hepatocytes with preservation of hepatocyte differentiation, function, and proliferative capacity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127816     DOI: 10.1006/jsre.2002.6446

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy.

Authors:  Zun Chang Liu; Thomas Ming Swi Chang
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models.

Authors:  Sang Woo Lee; Da Jung Jung; Gi Seok Jeong
Journal:  Tissue Eng Regen Med       Date:  2020-03-23       Impact factor: 4.169

3.  Primary hepatocyte culture in collagen gel mixture and collagen sandwich.

Authors:  Ying-Jie Wang; Hong-Ling Liu; Hai-Tao Guo; Hong-Wei Wen; Jun Liu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

4.  Keratinocyte serum-free medium maintains long-term liver gene expression and function in cultured rat hepatocytes by preventing the loss of liver-enriched transcription factors.

Authors:  Wan-Chun Li; Kate L Ralphs; Jonathan M W Slack; David Tosh
Journal:  Int J Biochem Cell Biol       Date:  2006-10-28       Impact factor: 5.085

5.  In vitro Differentiation of Human TERT-Transfected Multi-Lineage Progenitor Cells (MLPC) into Immortalized Hepatocyte-Like Cells.

Authors:  Daniel P Collins; Joel H Hapke; Rajagopal N Aravalli; Clifford J Steer
Journal:  Hepat Med       Date:  2020-06-11

6.  Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes.

Authors:  Tanja Deurholt; Niek P van Til; Aniska A Chhatta; Lysbeth ten Bloemendaal; Ruth Schwartlander; Catherine Payne; John N Plevris; Igor M Sauer; Robert Afm Chamuleau; Ronald Pj Oude Elferink; Jurgen Seppen; Ruurdtje Hoekstra
Journal:  BMC Biotechnol       Date:  2009-10-21       Impact factor: 2.563

Review 7.  Advances in HBV infection and replication systems in vitro.

Authors:  Ruirui Xu; Pingping Hu; Yuwen Li; Anran Tian; Jun Li; Chuanlong Zhu
Journal:  Virol J       Date:  2021-05-29       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.